Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    "methodist hospital" | Open Studies | "Coronary Artery Disease" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Unknown  Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: Regadenoson
2 Not yet recruiting Reducing Radioisotope Dose: the Half-Dose CZT Study
Condition: Coronary Artery Disease
Intervention: Radiation: Comparison of the image quality of the half-dose (cadmium zinc telluride) CZT versus full dose scans
3 Recruiting ABSORB III Randomized Controlled Trial (RCT)
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
4 Unknown  Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Condition: Coronary Artery Disease
Intervention:
5 Recruiting Absorb IV Randomized Controlled Trial
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
6 Recruiting The PzF Shield Trial
Condition: Coronary Artery Disease
Intervention: Device: COBRA PzF
7 Recruiting International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
8 Recruiting A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
Conditions: Congestive Heart Failure;   Left Ventricular (LV) Systolic Dysfunction
Intervention: Device: CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
9 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo

Indicates status has not been verified in more than two years